Reference
Ross Southworth M, et al. Dabigatran and Postmarketing Reports of Bleeding. New England Journal of Medicine 368: 1272-1274, No. 14, 4 Apr 2013. Available from: URL: http://dx.doi.org/10.1056/NEJMp1302834
Rights and permissions
About this article
Cite this article
Risk of bleeding with dabigatran not higher than with warfarin. Reactions Weekly 1447, 2 (2013). https://doi.org/10.1007/s40278-013-2365-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-2365-x